(AOF) – L’Oréal has signed an agreement to acquire Skinbetter Science, “American skincare brand at the forefront of dermatological research”. It achieved sales of more than $95 million over the rolling twelve months to July 31, 2022. “The brand’s growth is one of the strongest among prescribed skincare brands in the United States”, specifies the French firm.
Skinbetter Science products are primarily prescribed by a network of top dermatologists, plastic surgeons, and aesthetic physicians in the United States and distributed by a nationwide medical team.
The current management team will continue to manage the business from the headquarters in Arizona, under the supervision of Christina Fair, president of the Active Cosmetics Division of L’Oréal USA.
This acquisition is expected to close in early Q4 2022, subject to customary regulatory approvals and other customary closing conditions.
The AOF information reproduced on Capital.fr is taken from the AOF information service. This information is protected by intellectual property rights held by OPTION FINANCE SAS, publisher of the AOF real-time stock market information service, and its contributors. Consequently, any reproduction, copy, duplication, modification, transfer, redistribution, translation, commercial exploitation or not, creation of a hypertext link or reuse in any way whatsoever of this information is subject to the prior written consent of OPTION. FINANCE SAS and its contributors. AOF can be reached at the following address [email protected] OPTION FINANCE SAS collects its data from the sources it considers the safest. However, subject to its gross negligence, OPTION FINANCES SAS and its contributors do not in any way guarantee the absence of error and defects, even hidden ones, nor the exhaustive nature or the lack of conformity for any use whatsoever of this data and of OPTION FINANCE SAS or one of its contributors, and cannot be held responsible for any delays or interruptions that may affect access to them. The user of the OPTION FINANCE SAS service will use the AOF data at his own risk and must hold OPTION FINANCE SAS and its contributors harmless from any claim resulting from this use.
Receive our latest news
Every morning, the information to remember on the financial markets.